HomeCDXS • NASDAQ
add
Codexis Inc
Previous close
$3.56
Day range
$3.37 - $3.63
Year range
$1.45 - $4.91
Market cap
249.07M USD
Avg Volume
455.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Top news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 17.07M | 31.51% |
Operating expense | 24.11M | 56.54% |
Net income | -11.50M | 49.13% |
Net profit margin | -67.39 | 61.32% |
Earnings per share | -0.16 | 53.20% |
EBITDA | -10.51M | 52.51% |
Effective tax rate | -0.09% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 85.52M | -16.84% |
Total assets | 149.56M | -31.42% |
Total liabilities | 70.29M | -23.64% |
Total equity | 79.27M | — |
Shares outstanding | 69.85M | — |
Price to book | 3.15 | — |
Return on assets | -20.77% | — |
Return on capital | -26.40% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -11.50M | 49.13% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications. Wikipedia
CEO
Founded
2002
Headquarters
Website
Employees
174